Akebia Therapeutics®, Inc. (“Akebia”) (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of ...

This move aims to provide relief to founders of new-age technology companies who often receive ESOPs instead of cash-based ...

Read about the completion of Trive Capital-backed Karman Space & Defense's IPO, which raised over $500 million in capital.

The offering is expected to be a key test of appetite for AI-focused companies after the launch of Chinese startup DeepSeek's ...

Akebia Therapeutics shares were down 20% to $2.27 after the company priced its underwritten public offering of 25 million shares at $2 a share. All shares are being offered by Akebia. The proceeds to ...

It’s DoorDash’s first BNPL alliance and gives users of the restaurant delivery service a new way to pay for meals ...

CoreWeave Inc., a cloud-computing provider that’s one of the hottest startups in artificial intelligence, and some of its ...

Roth Capital Partners and Clear Street LLC are acting as active joint book-running managers for the Offering. Rosenblatt Securities Inc. is acting as a passive book-running manager. The Benchmark ...

The shares are being offered by Akebia pursuant to a shelf registration statement that was filed with the Securities and Exchange Commission (“SEC”) on September 3, 2024 and declared effective by the ...

Shares of Akebia Therapeutics fell after the company said it has commenced an underwritten public offering. The stock sank 21% to $2.24 in after-hours trading Wednesday. Shares ended the regular ...

The Philippine Stock Exchange Inc. (PSE), the operator of the country’s capital market, has allowed companies that will raise ...

The move comes as the firm’s IPO targeting women and minority investors for a planned $1 billion-plus gaming complex in ...